Month: May 2026

An iridescent abstract render of a human brain on a deep blue and purple background, evoking modern neuroscience.

CGRP Medications for Migraine in 2026 — Emgality, Ajovy, Vyepti and Aimovig

Posted on by Dr Granot
Australia now has four CGRP monoclonal antibodies for migraine — Emgality, Ajovy and Vyepti are PBS-subsidised for chronic migraine, while Aimovig is registered but private only. Dr Ron Granot explains how each works, PBS eligibility, what to expect, and how CGRP compares with Botox in 2026.
A woman leans against a softly lit wall holding her head in a thoughtful, contemplative pose suggesting chronic migraine.

Botox for Chronic Migraine in 2026 — and Why “Follow the Pain” Matters

Posted on by Dr Granot
Botox is a well-evidenced preventative for chronic migraine. The PREEMPT protocol is the floor — what really matters is the bespoke 'follow the pain' approach: adding injections at each patient's individual pain distribution. Dr Ron Granot explains the why and how in 2026.
A digital blood pressure monitor and cuff resting on a calm clinical table, ready for autonomic testing.

POTS in Sydney: What to Expect from Your Autonomic Testing

Posted on by Dr Granot
POTS — postural orthostatic tachycardia syndrome — is under-diagnosed in Sydney, with an average 5–7 year delay to diagnosis. Dr Ron Granot explains what POTS is, when to suspect it, what specialist autonomic testing involves, and how to access rapid assessment in Sydney.